Matches in Nanopublications for { ?s ?p "[In this way, we found that knockdown of protein kinase D3 (PRKD3) could enhance cell killing of RAF and MEK inhibitors across multiple melanoma cell lines of various genotypes and sensitivities to RAF265.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP877053.RAaNKLfSUvafrUiQPeIhdkuRnxpplf8BG6UAd1MQUaGHw130_assertion description "[In this way, we found that knockdown of protein kinase D3 (PRKD3) could enhance cell killing of RAF and MEK inhibitors across multiple melanoma cell lines of various genotypes and sensitivities to RAF265.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877053.RAaNKLfSUvafrUiQPeIhdkuRnxpplf8BG6UAd1MQUaGHw130_provenance.
- assertion description "[In this way, we found that knockdown of protein kinase D3 (PRKD3) could enhance cell killing of RAF and MEK inhibitors across multiple melanoma cell lines of various genotypes and sensitivities to RAF265.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In this way, we found that knockdown of protein kinase D3 (PRKD3) could enhance cell killing of RAF and MEK inhibitors across multiple melanoma cell lines of various genotypes and sensitivities to RAF265.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP890306.RADULYfSB8H9eL5QnL0yJ2ahfneDkgrMQP84wq_YJic-8130_assertion description "[In this way, we found that knockdown of protein kinase D3 (PRKD3) could enhance cell killing of RAF and MEK inhibitors across multiple melanoma cell lines of various genotypes and sensitivities to RAF265.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890306.RADULYfSB8H9eL5QnL0yJ2ahfneDkgrMQP84wq_YJic-8130_provenance.
- NP890307.RAskyiqkadtkNDNASivuZNMCb3vK6bIuMNi31tc79lcwc130_assertion description "[In this way, we found that knockdown of protein kinase D3 (PRKD3) could enhance cell killing of RAF and MEK inhibitors across multiple melanoma cell lines of various genotypes and sensitivities to RAF265.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890307.RAskyiqkadtkNDNASivuZNMCb3vK6bIuMNi31tc79lcwc130_provenance.